Update on biomarkers in neuromyelitis optica
Neuromyelitis optica (NMO) (and NMO spectrum disorder) is an autoimmune inflammatory disease of the CNS primarily affecting spinal cord and optic nerves. Reliable and sensitive biomarkers for onset, relapse, and progression in NMO are urgently needed because of the heterogeneous clinical presentatio...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
July 23, 2015
|
| In: |
Neurology: Neuroimmunology & Neuroinflammation ; official journal of the American Academy of Neurology
Year: 2015, Volume: 2, Issue: 4 |
| ISSN: | 2332-7812 |
| DOI: | 10.1212/NXI.0000000000000134 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1212/NXI.0000000000000134 Verlag, lizenzpflichtig, Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516398/ |
| Author Notes: | Esther Melamed, MD, PhD, Michael Levy, MD, PhD, Patrick J. Waters, PhD, Douglas Kazutoshi Sato,MD, PhD, Jeffrey L. Bennett, MD, PhD, Gareth R. John, PhD, Douglas C. Hooper, PhD, Albert Saiz, MDAmit Bar-Or, MD, PhD, Ho Jin Kim, MD, Lakha Pandit, MD, Maria Isabel Leite, MD,DPhil, Nasrin Asgari, MD, PhD, Najib Kissani, MD, Rogier Hintzen, MD, PhD, Romain Marignier, MD, Sven Jarius, MD, John Marcelletti, PhD, Terry J. Smith, MD, Michael R. Yeaman, PhD, May H. Han, MD, On behalf of the GJCF-ICC&BR |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1700517023 | ||
| 003 | DE-627 | ||
| 005 | 20230427020149.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200612s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1212/NXI.0000000000000134 |2 doi | |
| 035 | |a (DE-627)1700517023 | ||
| 035 | |a (DE-599)KXP1700517023 | ||
| 035 | |a (OCoLC)1341339354 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Melamed, Esther |e VerfasserIn |0 (DE-588)1211853667 |0 (DE-627)1700517740 |4 aut | |
| 245 | 1 | 0 | |a Update on biomarkers in neuromyelitis optica |c Esther Melamed, MD, PhD, Michael Levy, MD, PhD, Patrick J. Waters, PhD, Douglas Kazutoshi Sato,MD, PhD, Jeffrey L. Bennett, MD, PhD, Gareth R. John, PhD, Douglas C. Hooper, PhD, Albert Saiz, MDAmit Bar-Or, MD, PhD, Ho Jin Kim, MD, Lakha Pandit, MD, Maria Isabel Leite, MD,DPhil, Nasrin Asgari, MD, PhD, Najib Kissani, MD, Rogier Hintzen, MD, PhD, Romain Marignier, MD, Sven Jarius, MD, John Marcelletti, PhD, Terry J. Smith, MD, Michael R. Yeaman, PhD, May H. Han, MD, On behalf of the GJCF-ICC&BR |
| 264 | 1 | |c July 23, 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 12.06.2020 | ||
| 520 | |a Neuromyelitis optica (NMO) (and NMO spectrum disorder) is an autoimmune inflammatory disease of the CNS primarily affecting spinal cord and optic nerves. Reliable and sensitive biomarkers for onset, relapse, and progression in NMO are urgently needed because of the heterogeneous clinical presentation, severity of neurologic disability following relapses, and variability of therapeutic response. Detecting aquaporin-4 (AQP4) antibodies (AQP4-IgG or NMO-IgG) in serum supports the diagnosis of seropositive NMO. However, whether AQP4-IgG levels correlate with disease activity, severity, response to therapy, or long-term outcomes is unclear. Moreover, biomarkers for patients with seronegative NMO have yet to be defined and validated. Collaborative international studies hold great promise for establishing and validating biomarkers that are useful in therapeutic trials and clinical management. In this review, we discuss known and potential biomarkers for NMO. | ||
| 700 | 1 | |a Levy, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Waters, Patrick J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sato, Douglas Kazutoshi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bennett, Jeffrey L. |e VerfasserIn |4 aut | |
| 700 | 1 | |a John, Gareth R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hooper, Douglas C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Saiz, Albert |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bar-Or, Amit |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kim, Ho Jin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pandit, Lakha |e VerfasserIn |4 aut | |
| 700 | 1 | |a Leite, Maria Isabel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Asgari, Nasrin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kissani, Najib |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hintzen, Rogier |e VerfasserIn |4 aut | |
| 700 | 1 | |a Marignier, Romain |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jarius, Sven |e VerfasserIn |0 (DE-588)1054615918 |0 (DE-627)791654818 |0 (DE-576)410367478 |4 aut | |
| 700 | 1 | |a Marcelletti, John |e VerfasserIn |4 aut | |
| 700 | 1 | |a Smith, Terry J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Yeaman, Michael R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Han, May H. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neurology: Neuroimmunology & Neuroinflammation ; official journal of the American Academy of Neurology |d Philadelphia, Pa. : Wolters Kluwer, 2014 |g 2(2015,4) Artikel-Nummer e134, 8 Seiten |h Online-Ressource |w (DE-627)784191956 |w (DE-600)2767740-0 |w (DE-576)404866883 |x 2332-7812 |7 nnas |a Update on biomarkers in neuromyelitis optica |
| 773 | 1 | 8 | |g volume:2 |g year:2015 |g number:4 |a Update on biomarkers in neuromyelitis optica |
| 856 | 4 | 0 | |u https://doi.org/10.1212/NXI.0000000000000134 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516398/ |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200612 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 1054615918 |a Jarius, Sven |m 1054615918:Jarius, Sven |d 910000 |d 911100 |e 910000PJ1054615918 |e 911100PJ1054615918 |k 0/910000/ |k 1/910000/911100/ |p 17 | ||
| 999 | |a KXP-PPN1700517023 |e 3686649047 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"origin":[{"dateIssuedDisp":"July 23, 2015","dateIssuedKey":"2015"}],"title":[{"title":"Update on biomarkers in neuromyelitis optica","title_sort":"Update on biomarkers in neuromyelitis optica"}],"note":["Gesehen am 12.06.2020"],"recId":"1700517023","type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"given":"Esther","family":"Melamed","display":"Melamed, Esther","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Levy, Michael","given":"Michael","family":"Levy","role":"aut","roleDisplay":"VerfasserIn"},{"display":"Waters, Patrick J.","given":"Patrick J.","family":"Waters","role":"aut","roleDisplay":"VerfasserIn"},{"family":"Sato","given":"Douglas Kazutoshi","display":"Sato, Douglas Kazutoshi","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Bennett, Jeffrey L.","family":"Bennett","given":"Jeffrey L.","role":"aut","roleDisplay":"VerfasserIn"},{"display":"John, Gareth R.","given":"Gareth R.","family":"John","role":"aut","roleDisplay":"VerfasserIn"},{"given":"Douglas C.","family":"Hooper","display":"Hooper, Douglas C.","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Saiz","given":"Albert","display":"Saiz, Albert","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","role":"aut","given":"Amit","family":"Bar-Or","display":"Bar-Or, Amit"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Kim, Ho Jin","given":"Ho Jin","family":"Kim"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Pandit, Lakha","given":"Lakha","family":"Pandit"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Leite, Maria Isabel","family":"Leite","given":"Maria Isabel"},{"roleDisplay":"VerfasserIn","role":"aut","family":"Asgari","given":"Nasrin","display":"Asgari, Nasrin"},{"given":"Najib","family":"Kissani","display":"Kissani, Najib","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","role":"aut","family":"Hintzen","given":"Rogier","display":"Hintzen, Rogier"},{"roleDisplay":"VerfasserIn","role":"aut","given":"Romain","family":"Marignier","display":"Marignier, Romain"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Jarius, Sven","family":"Jarius","given":"Sven"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Marcelletti, John","family":"Marcelletti","given":"John"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Smith, Terry J.","given":"Terry J.","family":"Smith"},{"display":"Yeaman, Michael R.","given":"Michael R.","family":"Yeaman","role":"aut","roleDisplay":"VerfasserIn"},{"given":"May H.","family":"Han","display":"Han, May H.","roleDisplay":"VerfasserIn","role":"aut"}],"relHost":[{"id":{"issn":["2332-7812"],"eki":["784191956"],"zdb":["2767740-0"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Update on biomarkers in neuromyelitis opticaNeurology: Neuroimmunology & Neuroinflammation ; official journal of the American Academy of Neurology","part":{"issue":"4","text":"2(2015,4) Artikel-Nummer e134, 8 Seiten","volume":"2","year":"2015"},"recId":"784191956","note":["Gesehen am 28.04.14"],"title":[{"title_sort":"Neurology: Neuroimmunology & Neuroinflammation ; official journal of the American Academy of Neurology","title":"Neurology: Neuroimmunology & Neuroinflammation ; official journal of the American Academy of Neurology"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"2014-","publisher":"Wolters Kluwer ; Lippincott Williams & Wilkins","publisherPlace":"Philadelphia, Pa. ; Philadelphia, Pa.","dateIssuedKey":"2014"}],"pubHistory":["1.2014 -"],"language":["eng"]}],"name":{"displayForm":["Esther Melamed, MD, PhD, Michael Levy, MD, PhD, Patrick J. Waters, PhD, Douglas Kazutoshi Sato,MD, PhD, Jeffrey L. Bennett, MD, PhD, Gareth R. John, PhD, Douglas C. Hooper, PhD, Albert Saiz, MDAmit Bar-Or, MD, PhD, Ho Jin Kim, MD, Lakha Pandit, MD, Maria Isabel Leite, MD,DPhil, Nasrin Asgari, MD, PhD, Najib Kissani, MD, Rogier Hintzen, MD, PhD, Romain Marignier, MD, Sven Jarius, MD, John Marcelletti, PhD, Terry J. Smith, MD, Michael R. Yeaman, PhD, May H. Han, MD, On behalf of the GJCF-ICC&BR"]},"id":{"eki":["1700517023"],"doi":["10.1212/NXI.0000000000000134"]}} | ||
| SRT | |a MELAMEDESTUPDATEONBI2320 | ||